| 1 |
34167925 | Prostate-specific Membrane Antigen Biology in Lethal Prostate Cancer and its Therapeutic Implications. | 2021 Jun 21 |
1 |
| 2 |
31492214 | 9,10-(Divinyl) Anthracene Based Bright Aggregation-Induced Emission Organic Dots for HeLa Cells Imaging. | 2020 Apr 1 |
1 |
| 3 |
30844704 | GCPII and its close homolog GCPIII: from a neuropeptidase to a cancer marker and beyond. | 2019 Mar 1 |
1 |
| 4 |
31099011 | Bioconjugated Gold Nanoparticles Enhance siRNA Delivery in Prostate Cancer Cells. | 2019 |
2 |
| 5 |
29141866 | Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors. | 2018 Jan 2 |
2 |
| 6 |
29680672 | Targeting of folate-conjugated liposomes with co-entrapped drugs to prostate cancer cells via prostate-specific membrane antigen (PSMA). | 2018 Jun |
2 |
| 7 |
30120883 | Association of FOLH1, DHFR, and MTHFR gene polymorphisms with susceptibility of Neural Tube Defects: A case control study from Eastern India. | 2018 Aug 15 |
2 |
| 8 |
28885600 | A Cross-Sectional Study of Dietary and Genetic Predictors of Blood Folate Levels in Healthy Young Adults. | 2017 Sep 8 |
3 |
| 9 |
27183249 | Synthesis and characterization of a pH responsive folic acid functionalized polymeric drug delivery system. | 2016 Jul-Aug |
2 |
| 10 |
27188645 | Bioconjugated gold nanoparticles enhance cellular uptake: A proof of concept study for siRNA delivery in prostate cancer cells. | 2016 Jul 25 |
2 |
| 11 |
27378204 | Ligand-targeted bacterial minicells: Futuristic nano-sized drug delivery system for the efficient and cost effective delivery of shRNA to cancer cells. | 2016 Nov |
1 |
| 12 |
27387982 | Prostate-specific membrane antigen (PSMA)-mediated laminin proteolysis generates a pro-angiogenic peptide. | 2016 Oct |
3 |
| 13 |
27389146 | Folate-targeted amphiphilic cyclodextrin.siRNA nanoparticles for prostate cancer therapy exhibit PSMA mediated uptake, therapeutic gene silencing in vitro and prolonged circulation in vivo. | 2016 Nov |
6 |
| 14 |
27917408 | Prostate-Specific Membrane Antigen Targeted Polymersomes for Delivering Mocetinostat and Docetaxel to Prostate Cancer Cell Spheroids. | 2016 Nov 30 |
1 |
| 15 |
26028103 | Genetic Variation in Glutamate Carboxypeptidase II and Interaction with Dietary Natural Vitamin C May Predict Risk for Adenomatous Polyp Occurrence. | 2015 |
3 |
| 16 |
26471812 | Clinical utility of genetic variants of glutamate carboxypeptidase II in predicting breast cancer and prostate cancer risk. | 2015 Nov |
1 |
| 17 |
24863754 | Structural and biochemical characterization of the folyl-poly-γ-l-glutamate hydrolyzing activity of human glutamate carboxypeptidase II. | 2014 Jul |
8 |
| 18 |
22918695 | The maternal folate hydrolase gene polymorphism is associated with neural tube defects in a high-risk Chinese population. | 2013 Mar |
2 |
| 19 |
23266799 | Association of glutamate carboxypeptidase II (GCPII) haplotypes with breast and prostate cancer risk. | 2013 Mar 1 |
1 |
| 20 |
23777916 | PSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancer. | 2013 Sep |
1 |
| 21 |
22310383 | Paradoxical role of C1561T glutamate carboxypeptidase II (GCPII) genetic polymorphism in altering disease susceptibility. | 2012 Apr 15 |
1 |
| 22 |
19830782 | Expression of prostate-specific membrane antigen (PSMA), increases cell folate uptake and proliferation and suggests a novel role for PSMA in the uptake of the non-polyglutamated folate, folic acid. | 2010 Feb 15 |
12 |
| 23 |
18234225 | Structural basis of interactions between human glutamate carboxypeptidase II and its substrate analogs. | 2008 Mar 7 |
2 |
| 24 |
18842806 | Associations between single nucleotide polymorphisms in folate uptake and metabolizing genes with blood folate, homocysteine, and DNA uracil concentrations. | 2008 Oct |
3 |
| 25 |
18974153 | Moderate expression of prostate-specific membrane antigen, a tissue differentiation antigen and folate hydrolase, facilitates prostate carcinogenesis. | 2008 Nov 1 |
3 |
| 26 |
19172696 | The reduced folate carrier (RFC1) 80G > A and folate hydrolase 1 (FOLH1) 1561C > T polymorphisms and the risk of colorectal cancer: a nested case-referent study. | 2008 |
3 |
| 27 |
17684227 | Relations of glutamate carboxypeptidase II (GCPII) polymorphisms to folate and homocysteine concentrations and to scores of cognition, anxiety, and depression in a homogeneous Norwegian population: the Hordaland Homocysteine Study. | 2007 Aug |
4 |
| 28 |
16496414 | Prostate specific membrane antigen (PSMA) expression gives prostate cancer cells a growth advantage in a physiologically relevant folate environment in vitro. | 2006 Jun 1 |
3 |
| 29 |
15588157 | Genetic determinants of folate status in Central Bohemia. | 2005 |
2 |
| 30 |
15837926 | Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase. | 2005 Apr 26 |
2 |
| 31 |
15147814 | Enhanced in vitro DNA transfection efficiency by novel folate-linked nanoparticles in human prostate cancer and oral cancer. | 2004 May 31 |
2 |
| 32 |
15321811 | Bioavailability of polyglutamyl folic acid relative to that of monoglutamyl folic acid in subjects with different genotypes of the glutamate carboxypeptidase II gene. | 2004 Sep |
2 |
| 33 |
15337665 | Folate, homocysteine, and negative symptoms in schizophrenia. | 2004 Sep |
2 |
| 34 |
20641246 | Quantum dot-prostate-specific membrane antigen antibody J591 | 2004 |
1 |
| 35 |
20641248 | N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-S-[11C]methyl-L-cysteine | 2004 |
1 |
| 36 |
20641404 | 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-anti-prostate-specific membrane antigen 3/A12 monoclonal antibody | 2004 |
1 |
| 37 |
20641595 | N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine | 2004 |
1 |
| 38 |
20662139 | IRDye800-2-(3-{5-[7-(5-amino-1-carboxy-pentylcarbamoyl)-heptanoylamino]-1-carboxy-pentyl}-ureido)-pentanedioic acid | 2004 |
1 |
| 39 |
21634075 | Quantum dot 800–prostate-specific membrane antigen antibody J591 | 2004 |
1 |
| 40 |
22379638 | 89Zr-Desferrioxamine B-7E11 anti-prostate-specific membrane antigen monoclonal antibody | 2004 |
1 |
| 41 |
22400137 | Quenched indocyanine green-anti-prostate-specific membrane antigen antibody J591 | 2004 |
1 |
| 42 |
23256224 | 2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid | 2004 |
1 |
| 43 |
23256225 | 111In-Labeled (7S)-26-(4-((1-((1-carboxy-5-(2-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetamido)pentyl)amino)-1-oxo-6-(1-((7S)-1,3,7,22-tetracarboxy-5,13,20-trioxo-4,6,12,21-tetraazahexacosan-26-yl)-1H-1,2,3-triazole-4-carboxamido)hexan-2-yl)carbamoyl)-1H-1,2,3-triazol-5-yl)-5,13,20-trioxo-4,6,12,21-tetraazahexacosane-1,3,7,22-tetracarboxylic acid | 2004 |
1 |
| 44 |
23586109 | Cy7-(3S,7S)-26-Amino-5,13,20-trioxo-4,6,12,21-tetraazahexacosane-1,3,7,22-tetracarboxylic acid | 2004 |
1 |
| 45 |
12514270 | The H475Y polymorphism in the glutamate carboxypeptidase II gene increases plasma folate without affecting the risk for neural tube defects in humans. | 2003 Jan |
8 |
| 46 |
12707400 | Effect of glutamate carboxypeptidase II and reduced folate carrier polymorphisms on folate and total homocysteine concentrations in dialysis patients. | 2003 May |
6 |
| 47 |
12753319 | Effects of the glutamate carboxypeptidase II (GCP2 1561C>T) and reduced folate carrier (RFC1 80G>A) allelic variants on folate and total homocysteine levels in kidney transplant patients. | 2003 Jun |
2 |
| 48 |
12855225 | Evaluation of genetic variants in the reduced folate carrier and in glutamate carboxypeptidase II for spina bifida risk. | 2003 Jul |
2 |
| 49 |
12949938 | Effect of carbohydrate moieties on the folate hydrolysis activity of the prostate specific membrane antigen. | 2003 Oct 1 |
1 |
| 50 |
12042430 | The glutamate carboxypeptidase gene II (C>T) polymorphism does not affect folate status in the Framingham Offspring cohort. | 2002 Jun |
1 |